# EGF

## Overview
The EGF gene encodes the epidermal growth factor, a critical protein involved in numerous cellular processes, including cell growth, proliferation, and differentiation. EGF is a small peptide that functions by binding to the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, thereby initiating a cascade of intracellular signaling pathways. These pathways are essential for regulating various physiological processes such as embryonic development, tissue repair, and cellular homeostasis (Wee2017Epidermal; Purba2017Activation). The EGF protein is characterized by its conserved cysteine-rich structure, which forms disulfide-bonded loops crucial for its stability and function (Appella1988Structure). EGF's interaction with EGFR is a well-studied model of receptor-ligand dynamics, highlighting its role in mediating complex biological responses through precise protein-protein interactions (Rungnim2016Protein–protein; Yarden1987Epidermal).

## Structure
The Epidermal Growth Factor (EGF) protein is a small peptide consisting of 53 amino acids, characterized by its primary structure, which includes a sequence of conserved cysteine residues that form three disulfide-bonded loops. These disulfide bonds are crucial for the protein's secondary structure, contributing to its stability and compact, globular tertiary structure (Appella1988Structure). EGF modules are typically about 45 residues long and contain three disulfide bridges, which are essential for mediating protein-protein interactions (Campbell1993Epidermal).

The EGF module is found in various proteins, including those involved in blood coagulation and cell adhesion, and is often associated with other structural modules like immunoglobulin superfamily modules and fibronectin type III modules (Campbell1993Epidermal). Structural studies using NMR and X-ray crystallography have shown that EGF modules have a tendency for alpha-helix formation in specific regions, with a structure similar to tissue growth factor (TGF)-alpha (Campbell1993Epidermal). EGF does not exhibit a quaternary structure as it functions as a monomer. Post-translational modifications, such as glycosylation, are common in EGF, enhancing its functional diversity (Appella1988Structure).

## Function
The epidermal growth factor (EGF) is a protein that plays a significant role in various cellular processes in healthy human cells. EGF primarily functions by binding to its receptor, the epidermal growth factor receptor (EGFR), which is a receptor tyrosine kinase. This binding induces receptor dimerization and autophosphorylation, activating several downstream signaling pathways that regulate cell proliferation, differentiation, and survival (Wee2017Epidermal; Purba2017Activation).

EGF is involved in the regulation of cell motility, a critical process for embryonic development, tissue maintenance, and wound repair. The activation of EGFR by EGF can lead to cell motility through a PLCγ-dependent pathway, essential for actin cytoskeleton reorganization, and the MAP kinase pathway, which modulates integrin adhesive functions and disassembles focal adhesions (Jorissen2003Epidermal).

EGF also plays a crucial role in epithelial repair, particularly in the airway epithelium, by promoting cell migration and proliferation, which accelerates wound closure. This process can occur independently of cell proliferation, highlighting EGF's role in tissue regeneration (Burgel2004Roles). EGF's involvement in these processes underscores its importance in maintaining cellular architecture and facilitating cell movement in healthy human cells.

## Interactions
Epidermal growth factor (EGF) interacts with its receptor, the epidermal growth factor receptor (EGFR), to initiate a series of intracellular signaling events. EGF binding to EGFR induces receptor dimerization, a process that is crucial for receptor activation and subsequent signal transduction. This dimerization is rapid, reversible, and specific to EGF, involving noncovalent interactions that stabilize the receptor in its active form (Yarden1987Epidermal). The binding of EGF to EGFR also leads to conformational changes in the receptor's extracellular domain, which are essential for its activation (Greenfield1989Epidermal).

EGF can form both 1:1 and 2:2 complexes with the extracellular domain of EGFR, indicating a stoichiometric interaction that is important for understanding the binding dynamics and potential for therapeutic targeting (Domagala2000Stoichiometry). The interaction between EGF and EGFR is not only limited to dimerization but also involves the formation of hydrogen bonds and the preservation of specific secondary structural elements, such as antiparallel β-sheets, which are crucial for the stability of the EGF-EGFR complex (Rungnim2016Protein–protein).

EGF's interaction with EGFR is also linked to the activation of phosphoinositide kinases, which are associated with the receptor and play a role in the generation of second messengers involved in signal transduction pathways (Cochet1991Interaction).


## References


[1. (Rungnim2016Protein–protein) Chompoonut Rungnim, Thanyada Rungrotmongkol, Nawee Kungwan, and Supot Hannongbua. Protein–protein interactions between swcnt/chitosan/egf and egf receptor: a model of drug delivery system. Journal of Biomolecular Structure and Dynamics, 34(9):1919–1929, January 2016. URL: http://dx.doi.org/10.1080/07391102.2015.1095114, doi:10.1080/07391102.2015.1095114. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/07391102.2015.1095114)

[2. (Purba2017Activation) Endang Purba, Ei-ichiro Saita, and Ichiro Maruyama. Activation of the egf receptor by ligand binding and oncogenic mutations: the “rotation model”. Cells, 6(2):13, June 2017. URL: http://dx.doi.org/10.3390/cells6020013, doi:10.3390/cells6020013. This article has 177 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells6020013)

[3. (Greenfield1989Epidermal) C. Greenfield, I. Hiles, M.D. Waterfield, M. Federwisch, A. Wollmer, T.L. Blundell, and N. McDonald. Epidermal growth factor binding induces a conformational change in the external domain of its receptor. The EMBO Journal, 8(13):4115–4123, December 1989. URL: http://dx.doi.org/10.1002/j.1460-2075.1989.tb08596.x, doi:10.1002/j.1460-2075.1989.tb08596.x. This article has 126 citations.](https://doi.org/10.1002/j.1460-2075.1989.tb08596.x)

[4. (Campbell1993Epidermal) Iain D. Campbell and Peer Bork. Epidermal growth factor-like modules. Current Opinion in Structural Biology, 3(3):385–392, June 1993. URL: http://dx.doi.org/10.1016/s0959-440x(05)80111-3, doi:10.1016/s0959-440x(05)80111-3. This article has 282 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0959-440x(05)80111-3)

[5. (Burgel2004Roles) P-R Burgel. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax, 59(11):992–996, November 2004. URL: http://dx.doi.org/10.1136/thx.2003.018879, doi:10.1136/thx.2003.018879. This article has 189 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/thx.2003.018879)

[6. (Jorissen2003Epidermal) R Jorissen. Epidermal growth factor receptor: mechanisms of activation and signalling. Experimental Cell Research, 284(1):31–53, March 2003. URL: http://dx.doi.org/10.1016/s0014-4827(02)00098-8, doi:10.1016/s0014-4827(02)00098-8. This article has 1144 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-4827(02)00098-8)

[7. (Domagala2000Stoichiometry) Teresa Domagala, Nicky Konstantopoulos, Fiona Smyth, Robert N. Jorissen, Louis Fabri, Detlef Geleick, Irit Lax, Joseph Schlessinger, William Sawyer, Geoffrey J. Howlett, Antony W. Burgess, and Edouard C. Nice. Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (egf) and the extracellular domain of the egf receptor. Growth Factors, 18(1):11–29, January 2000. URL: http://dx.doi.org/10.3109/08977190009003231, doi:10.3109/08977190009003231. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/08977190009003231)

[8. (Appella1988Structure) Ettore Appella, Irene T. Weber, and Francesco Blasi. Structure and function of epidermal growth factor‐like regions in proteins. FEBS Letters, 231(1):1–4, April 1988. URL: http://dx.doi.org/10.1016/0014-5793(88)80690-2, doi:10.1016/0014-5793(88)80690-2. This article has 244 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0014-5793(88)80690-2)

[9. (Wee2017Epidermal) Ping Wee and Zhixiang Wang. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers, 9(5):52, May 2017. URL: http://dx.doi.org/10.3390/cancers9050052, doi:10.3390/cancers9050052. This article has 1096 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers9050052)

[10. (Yarden1987Epidermal) Yosef Yarden and Joseph Schlessinger. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry, 26(5):1443–1451, March 1987. URL: http://dx.doi.org/10.1021/bi00379a035, doi:10.1021/bi00379a035. This article has 463 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi00379a035)

[11. (Cochet1991Interaction) C Cochet, O Filhol, B Payrastre, T Hunter, and G N Gill. Interaction between the epidermal growth factor receptor and phosphoinositide kinases. Journal of Biological Chemistry, 266(1):637–644, January 1991. URL: http://dx.doi.org/10.1016/s0021-9258(18)52482-0, doi:10.1016/s0021-9258(18)52482-0. This article has 103 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)52482-0)